B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HPGD

MOLECULAR TARGET

15-hydroxyprostaglandin dehydrogenase

UniProt: P15428NCBI Gene: 324825 compounds

HPGD (15-hydroxyprostaglandin dehydrogenase) is targeted by 25 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HPGD

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram1.795
2Genistein1.614
3myricetin-3-O-galactopyranoside [Supplementary Concept]1.393
4Carmine Coloring matter from1.393
5Sulfinpyrazone1.393
6Apigenin 5,7,4'-trihydroxy-flavone,1.102
7Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
8Quercetin1.102
9Carbidopa1.102
10Masoprocol1.102
11pd980591.102
12Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.1.102
13Arachidonic Acid0.691
14Kaempferols0.691
15plumbagin [Supplementary Concept]0.691
16salvin [Supplementary Concept]0.691
17DEET0.691
18diallyl trisulfide0.691
19Ethidium0.691
20Hexachlorophene0.691
21hydroxyindoleacetic acid0.691
22Indomethacin0.691
23juglone hydroxylase [Supplementary Concept] catalyzes0.691
24Linoleic Acid0.691
25Niflumic Acid0.691

About HPGD as a Drug Target

HPGD (15-hydroxyprostaglandin dehydrogenase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 25 compounds with documented HPGD interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HPGD inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.